HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrocodone Bitartrate, Chlorpheniramine Maleate And Pseudoephedrine Hydrochloride, and what generic alternatives are available?
Hydrocodone Bitartrate, Chlorpheniramine Maleate And Pseudoephedrine Hydrochloride is a drug marketed by Mayne Pharma Inc, Padagis Us, Sciegen Pharms Inc, and Tris Pharma Inc. and is included in four NDAs.
The generic ingredient in HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE is chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE?
- What are the global sales for HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE?
- What is Average Wholesale Price for HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE?
Summary for HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
DailyMed Link: | HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE at DailyMed |